common.study.topics.clinical

Polyol Pathway in the Central Nervous System

common.study.values.description

“Investigating the Role of the Polyol Pathway in the Central Nervous System”

Patients will undergo magnetic resonance spectroscopy (MRS) scanning to noninvasively measure intracerebral and plasma metabolite levels at baseline and following 2 and 4 hours of hyperglycemia. Subjects will also undergo a lumbar puncture at a separate occasion to assess cerebrospinal fluid levels of metabolites.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Brain MRS during hyperglycemic clamp

All patients will undergo brain MRS at baseline and following 2 and 4 hours of hyperglycemia using the clamp technique

Analysis of Metabolites in cerebrospinal fluid

All patients will have the option to undergo a lumbar puncture for analysis of metabolites in cerebrospinal fluid

participant.views.study.view.additional

participant.views.study.view.scientific-title

Investigating the Role of Polyol Pathway in the Central Nervous System

common.study.values.clinical-trial-id

NCT02272556

participant.views.study.view.id

mbkoYb